Genevoyager offers diverse collaboration models, including licensing, customized CMC development, and end-to-end CDMO services. With robust and compliant industrial-scale manufacturing capabilities, we accelerate the R&D and clinical translation of partners’ in vivo CAR-T and gene therapy programs.

Note: Subject to adjustment based on client requirements.